871819-39-5

Basic information

• Product Name: 1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester
• Synonyms: 1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester;Methyl 3-(Methoxycarbonyl)-1-Methyl-1H-Pyrrole-2-acetate;methyl 2-(2-methoxy-2-oxoethyl)-1-methyl-1H-pyrrole-3-carboxylate;2-methoxycarbonylmethyl-1-methyl-1H-pyrrole-3-carboxylic acid methyl este
• CAS NO: 871819-39-5
• Molecular Formula: C10H13NO4
• Molecular Weight: 211.21452
• Mol File: 871819-39-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester(871819-39-5)
• EPA Substance Registry System: 1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester(871819-39-5)

Safety Data

• Hazardous Substances Data: 871819-39-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structural features and reactivity make it a valuable building block for the development of new drugs with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 1H-Pyrrole-2-acetic acid, 3-(methoxycarbonyl)-1-methyl-, methyl ester is utilized as a versatile reagent for the preparation of a wide range of organic compounds. The methoxycarbonyl group serves as a protective group, allowing for selective reactions and facilitating the synthesis of complex organic molecules.

Upstream product

• 67-56-1 methanol 
• 83863-74-5 2-(carboxymethyl)-1-methyl-1H-pyrrole-3-carboxylic acid 
• 542-05-2 acetonedicarboxylic acid 

Downstream Products

• 925917-92-6 1-methyl-7-(4-morpholinylcarbonyl)-4-{3-[(trifluoromethyl)oxy]phenyl}-1H-pyrrolo[3,2-c]pyridine hydrochloride 
• 925917-91-5 3-chloro-N-[1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridin-4-yl]benzamide hydrochloride 
• 925917-90-4 N-[(3-chlorophenyl)methyl]-1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridin-4-amine hydrochloride 
• 925917-53-9 4-[(3-chlorophenyl)oxy]-1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridine hydrochloride 
• 925917-93-7 4-(3-chlorophenyl)-1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridine hydrochloride 
• 925979-46-0 1-methyl-7-(4-morpholinylcarbonyl)-4-{3-[(trifluoromethyl)oxy]phenyl}-1H-pyrrolo[3,2-c]pyridine 
• 925979-45-9 3-chloro-N-[1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridin-4-yl]benzamide 
• 925979-44-8 N-[(3-chlorophenyl)methyl]-1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridin-4-amine 
• 925917-89-1 4-[(3-chlorophenyl)sulfonyl]-1-methyl-7-(1-piperidinylcarbonyl)-1H-pyrrolo[3,2-c]pyridine 
• 925917-88-0 4-[(3-chlorophenyl)thio]-1-methyl-7-(1-piperidinylcarbonyl)-1H-pyrrolo[3,2-c]pyridine 
• 925979-09-5 4-[(3-chlorophenyl)oxy]-1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridine 
• 925979-47-1 4-(3-chlorophenyl)-1-methyl-7-(4-morpholinylcarbonyl)-1H-pyrrolo[3,2-c]pyridine 
• 925917-49-3 1-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-7-carboxylic acid 
• 871819-42-0 1-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-7-carboxylic acid methyl ester 

Relevant articles and documents

Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin- 7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain

We report the synthesis and SAR of a series of novel azaindole CB 2 agonists. 6-Azaindole 18 showed activity in an acute pain model but was inactive in a chronic model. 18 is a Pgp substrate with low brain penetration. The template was redesign

COMBINATION OF CB2 LIGAND AND PARACETAMOL

Combination of one or more CB2 modulators and paracetamol are useful of treating conditions which are mediated by the activity of CB2 receptors such as an immune disorder, an inflammatory disorder, pain, rheumatoid arthritis, multiple sclerosis, osteoarthritis, and osteoporosis.

PYRROLOPYRIDINE DERIVATIVES

The present invention relates to novel pyrrolopyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.